166 related articles for article (PubMed ID: 826814)
1. [SMON].
Paal G
MMW Munch Med Wochenschr; 1976 Dec; 118(51):suppl [7]-[8]. PubMed ID: 826814
[No Abstract] [Full Text] [Related]
2. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].
Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y
Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219
[No Abstract] [Full Text] [Related]
3. Oxyquinoline neurotoxicity.
Guy-Grand B; Basdevant A; Soffer M
Lancet; 1983 Apr; 1(8331):933. PubMed ID: 6132266
[No Abstract] [Full Text] [Related]
4. Oxyquinoline toxicity.
Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
[No Abstract] [Full Text] [Related]
5. Chinese acupuncture treatment for SMON patients.
Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
[No Abstract] [Full Text] [Related]
6. [SMON outside Japan--a neurologic evaluation].
Silfverskiöld B
Lakartidningen; 1980 May; 77(19):1821-2. PubMed ID: 7392712
[No Abstract] [Full Text] [Related]
7. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
8. [Hydroxyquinoline victims in Sweden].
Hansson O
Lakartidningen; 1978 Sep; 75(36):3064-7. PubMed ID: 682760
[No Abstract] [Full Text] [Related]
9. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
10. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
Sturtevant FM
Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
[TBL] [Abstract][Full Text] [Related]
11. [SMON and chinoform].
Tamura Z
Tanpakushitsu Kakusan Koso; 1973 Mar; 18(3):210-4. PubMed ID: 4197094
[No Abstract] [Full Text] [Related]
12. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
13. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms].
Inoue N; Tamura K; Kuroiwa Y; Ysukochi T; Naritomi T
Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521
[No Abstract] [Full Text] [Related]
14. [Epidemiology of SMON--our experience with the occurrence in the hospital].
Ando K; Sobue I
Shinkei Kenkyu No Shimpo; 1971; 15(2):531-5. PubMed ID: 5106860
[No Abstract] [Full Text] [Related]
15. Toxicity of oxyquinolines.
Hansson O
Lancet; 1977 May; 1(8022):1152. PubMed ID: 68247
[No Abstract] [Full Text] [Related]
16. [Subacute myelo-optico-neuropathy].
Hallen O
Nervenarzt; 1980 Apr; 51(4):242-5. PubMed ID: 6775237
[No Abstract] [Full Text] [Related]
17. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
Tjälve H
Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
[TBL] [Abstract][Full Text] [Related]
18. [Suspected cases of SMON in Japan in the 13th year of Showa (1938)--clinicoepidemiological evaluation].
Takasu T; Toyokura Y; Nakae K; Katshira K; Sugiyama S
Nihon Rinsho; 1973 Mar; 31(3):692-9. PubMed ID: 4799633
[No Abstract] [Full Text] [Related]
19. More on S.M.O.N.
Lancet; 1971 Dec; 2(7736):1244. PubMed ID: 4143604
[No Abstract] [Full Text] [Related]
20. [SMON and chinoform: search for the causative agent].
Tsubaki T; Honma Y; Hoshi M
Naika; 1971; 28(3):451-5. PubMed ID: 5097705
[No Abstract] [Full Text] [Related]
[Next] [New Search]